MicroRNA-194 represses glioma cell epithelial‑to‑mesenchymal transition by targeting Bmi1.

MicroRNA-194 (miR-194) is frequently dysregulated in many types of cancer. However, the function of miR-194 in glioma remains unknown. In the present study, we aimed to investigate the biological functions of miR-194 in glioma and the potential molecular mechanism of miR-194 involved in glioma progression. We found that miR-194 expression was significantly reduced in glioma specimens and cell lines, as detected by real-time quantitative polymerase chain reaction (RT-qPCR) analysis. The overexpression of miR-194 inhibited while the suppression of miR-194 promoted cell migration, invasion and epithelial mesenchymal transition (EMT) in glioma cells. Bioinformatics analysis showed that the B cell-specific moloney murine leukemia virus insertion site 1 (Bmi1) was a direct target of miR-194, which was validated by dual-luciferase reporter assay, RT-qPCR and western blot analysis. The restoration of Bmi1 expression significantly abrogated the suppressive effect of miR-194 on glioma cell EMT. Taken together, the present study suggests that miR-194 inhibits glioma cell EMT by targeting Bmi1 providing novel insights into understanding the pathogenesis of glioma. The restoration of miR-194 may be a potential therapeutic strategy for glioma treatment.

[1]  Wen-Wei Chang,et al.  miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells , 2016, International journal of molecular sciences.

[2]  Xiaosheng Wang,et al.  MicroRNA-194 restrains the cell progression of non-small cell lung cancer by targeting human nuclear distribution protein C. , 2016, Oncology reports.

[3]  Youping Deng,et al.  miR‐376c inhibits cervical cancer cell proliferation and invasion by targeting BMI1 , 2016, International journal of experimental pathology.

[4]  Xiuping Liu,et al.  TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance , 2016, Journal of Cancer.

[5]  Qianfeng Zhuang,et al.  MiR-194 inhibits cell proliferation and invasion via repression of RAP2B in bladder cancer. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Dan Li,et al.  miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein , 2016, Oncotarget.

[7]  A. Evans,et al.  MicroRNA‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma , 2016, Cancer medicine.

[8]  Jing-Ping Liu,et al.  MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2. , 2016, International journal of oncology.

[9]  I. Pakzad,et al.  Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer , 2016, Tumor Biology.

[10]  Chunjiang Yu,et al.  MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway. , 2016, Biochemical and biophysical research communications.

[11]  Yongri Zheng,et al.  miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2. , 2015, Biochemical and biophysical research communications.

[12]  M. Christodoulou,et al.  Enzymatic Kinetic Resolution of 2-Piperidineethanol for the Enantioselective Targeted and Diversity Oriented Synthesis , 2015, International journal of molecular sciences.

[13]  Xizhong Zhang,et al.  MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. , 2015, International journal of clinical and experimental pathology.

[14]  T. Ma,et al.  Up-Regulation of MiR-452 Inhibits Metastasis of Non-Small Cell Lung Cancer by Regulating BMI1 , 2015, Cellular Physiology and Biochemistry.

[15]  Jianjun Liu,et al.  MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma. , 2015, Urologic oncology.

[16]  Chengming Ding,et al.  MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer. , 2015, Oncology letters.

[17]  Hua Niu,et al.  MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1 , 2015, International journal of molecular medicine.

[18]  X. Yang,et al.  MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1 , 2015, Tumor Biology.

[19]  K. Man,et al.  ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer , 2015, Oncotarget.

[20]  H. Chi.  miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  Guoqiang Zhao,et al.  miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells , 2015, Tumor Biology.

[22]  Tao Zhang,et al.  Role of Bmi-1 in Regulation of Ionizing Irradiation-Induced Epithelial-Mesenchymal Transition and Migration of Breast Cancer Cells , 2015, PloS one.

[23]  P. Wang,et al.  Bmi‐1 regulates the migration and invasion of glioma cells through p16 , 2015, Cell biology international.

[24]  W. Xue,et al.  Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1 , 2015, Biochemistry (Moscow).

[25]  Shan Wang,et al.  MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway , 2015, Cell cycle.

[26]  Jianjun Liu,et al.  miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3 , 2014, Journal of Translational Medicine.

[27]  G. Mukherjee,et al.  Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog , 2014, BMC Cancer.

[28]  Xiaoming Qi,et al.  MicroRNA‐320a inhibits cell proliferation, migration and invasion by targeting BMI‐1 in nasopharyngeal carcinoma , 2014, FEBS letters.

[29]  Piyun Sun,et al.  A novel NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1 , 2014, Tumor Biology.

[30]  Yaou Zhang,et al.  MiR-194 Deregulation Contributes To Colorectal Carcinogenesis via Targeting AKT2 Pathway , 2014, Theranostics.

[31]  X. Ying,et al.  MicroRNA-194 Inhibits the Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Targeting FoxM1 , 2014, Digestive Diseases and Sciences.

[32]  Lindsey J. Leach,et al.  miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27kip1 , 2014, Oncogene.

[33]  Min Shi,et al.  Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. , 2014, Oncology reports.

[34]  Y. Tu,et al.  Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in glioma patients , 2013, Journal of the Neurological Sciences.

[35]  D. Cui,et al.  MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. , 2013, Cancer research.

[36]  G. Nikkhah,et al.  Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. , 2013, Cancer letters.

[37]  K. McDonald,et al.  Current Progress for the Use of miRNAs in Glioblastoma Treatment , 2013, Molecular Neurobiology.

[38]  O. Slabý,et al.  MicroRNAs involved in chemo- and radioresistance of high-grade gliomas , 2013, Tumor Biology.

[39]  Xun Zhu,et al.  Bmi-1 Promotes Glioma Angiogenesis by Activating NF-κB Signaling , 2013, PloS one.

[40]  Jun Yu Li,et al.  Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway , 2012, BMC Cancer.

[41]  M. Karsy,et al.  Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme. , 2012, Genes & cancer.

[42]  Chengzhong Xing,et al.  microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer. , 2012, Experimental and therapeutic medicine.

[43]  T. Kamijo.  Role of stemness-related molecules in neuroblastoma , 2012, Pediatric Research.

[44]  T. Davis,et al.  BMI1 as a novel target for drug discovery in cancer , 2011, Journal of cellular biochemistry.

[45]  P. Dong,et al.  MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1 , 2011, Molecular Cancer.

[46]  Manfred Westphal,et al.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches , 2011, Nature Reviews Neuroscience.

[47]  Guang Yang,et al.  Down‐regulation of BMI‐1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells , 2011, Journal of cellular biochemistry.

[48]  Zhihong Wu,et al.  Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma , 2011, PloS one.

[49]  Sik Yoon,et al.  SNAI1 is Involved in the Proliferation and Migration of Glioblastoma Cells , 2011, Cellular and Molecular Neurobiology.

[50]  Y. Tomari,et al.  The microRNA pathway and cancer , 2010, Cancer science.

[51]  O. Lee,et al.  Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition , 2010, Nature Cell Biology.

[52]  I. Pollack.  Neuro-oncology: Therapeutic benefits of reirradiation for recurrent brain tumors , 2010, Nature Reviews Neurology.

[53]  Richard Beyer,et al.  TWIST1 promotes invasion through mesenchymal change in human glioblastoma , 2010, Molecular Cancer.

[54]  A. Lassman,et al.  Neuro-oncology: Late neurocognitive decline after radiotherapy for low-grade glioma , 2009, Nature Reviews Neurology.

[55]  J. Hodgson,et al.  microRNAs in Gliomas: Small Regulators of a Big Problem , 2009, NeuroMolecular Medicine.

[56]  Libing Song,et al.  Bmi-1, stem cells and cancer. , 2009, Acta biochimica et biophysica Sinica.

[57]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[58]  H. Ng,et al.  Oncogenic role of microRNAs in brain tumors , 2009, Acta Neuropathologica.

[59]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[60]  Peter Natesan Pushparaj,et al.  Oncomirs: The potential role of non-coding microRNAs in understanding cancer , 2008, Bioinformation.

[61]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[62]  F. Camacho,et al.  Implication of Polycomb Members Bmi-1, Mel-18, and Hpc-2 in the Regulation of p16INK4a, p14ARF, h-TERT, and c-Myc Expression in Primary Breast Carcinomas , 2006, Clinical Cancer Research.

[63]  Shirley Wu,et al.  Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[64]  D. Silbergeld,et al.  TWIST is expressed in human gliomas and promotes invasion. , 2005, Neoplasia.

[65]  M. Lohuizen,et al.  Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas , 2004, Nature.

[66]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[67]  S. Morrison,et al.  Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation , 2003, Nature.

[68]  Goberdhan P Dimri,et al.  Control of the Replicative Life Span of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1 , 2003, Molecular and Cellular Biology.

[69]  K Kornfeld,et al.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. , 1999, Genes & development.

[70]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[71]  Anindya Dutta,et al.  The role of microRNAs in glioma initiation and progression. , 2012, Frontiers in bioscience.